MichaelThomasMcHaleMD
Obstetrics & Gynecology • La Jolla, CAGynecologic Oncology
Clinical Professor, Department of Obstetrics & Gynecology Division Director, Gynecologic Oncology UCSD Moores Cancer Center
Dr. McHale is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9300 Campus Point Dr
La Jolla, CA 92037Phone+1 800-926-8273Fax+1 888-539-8781
Education & Training
University of California (Irvine)Fellowship, Gynecologic Oncology, 1999
National Capital ConsortiumResidency, Obstetrics and Gynecology, 1992 - 1996
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1992
Certifications & Licensure
CA State Medical License 1996 - 2025
MD State Medical License 1994 - 1997- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Top Doctors:San Diego Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Join now to see all
Clinical Trials
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 13
- Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Start of enrollment: 2012 Jun 04
- Join now to see all
Publications & Presentations
PubMed
- 384 citationsBreast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.William J Gradishar, Benjamin O Anderson, Jame Abraham, Rebecca Aft, Doreen Agnese
Journal of the National Comprehensive Cancer Network. 2020-04-01 - 144 citationsNCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.Deborah K Armstrong, Ronald D Alvarez, Floor J Backes, Jamie N Bakkum-Gamez, Lisa Barroilhet
Journal of the National Comprehensive Cancer Network. 2022-09-01 - 359 citationsOvarian cancer, version 2.2020Deborah K. Armstrong, Ronald D. Alvarez, Jamie N. Bakkum-Gamez, Lisa Barroilhet, Kian Behbakht
Journal of the National Comprehensive Cancer Network. 2021-02-02
Press Mentions
Endometriosis Could Lead to Higher Risk of Ovarian Cancer: StudyJuly 18th, 2024- Endometriosis Linked to Four-Fold Higher Odds for Ovarian CancerJuly 18th, 2024
- Risk of Ovarian Cancer Higher in Women with EndometriosisJuly 18th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
